Business Context and Reporting Period
Company: Super League Enterprise, Inc. (SLE)
Filing Type: Form 8-K (Current Report)
Date of Report: September 30, 2024
Event: Entry into a Material Definitive Agreement for a Series AAA-4 Junior Financing offering.
Key Financial Metrics and Transaction Details
This filing reports a capital raise rather than operational financial results. Key transaction metrics include:
- Gross Proceeds: $399,000 from the sale of 399 Units.
- Unit Composition: Each Unit consists of one share of Series AAA-4 Junior Convertible Preferred Stock and a warrant to purchase 1,000 shares of Common Stock.
- Purchase Price: $1,000 per Unit.
- Transaction Costs:
- Cash fee to Placement Agent: $39,900.
- Non-accountable expense allowance: $7,980.
- Placement Agent Warrants: 46,284 shares at $1.25 exercise price and 57,855 shares at $1.00 exercise price.
- Preferred Stock Terms:
- Stated Value: $1,000 per share.
- Initial Conversion Price: $1.25 per share.
- Dividends: 20% of underlying Common Stock shares payable on 30, 60, and 90-day anniversaries of the filing date.
- Investor Warrants: Exercisable immediately at $1.00 per share; expire three years from September 30, 2024.
Note: The filing does not provide current revenue, profit, cash flow, margins, or total debt figures.
Material Changes and Corporate Actions
- Capital Structure Change: Issuance of 399 shares of newly designated Series AAA-4 Junior Convertible Preferred Stock.
- Authorization: The Company filed a Certificate of Designation designating 400 shares of Series AAA-4 Preferred Stock (400 authorized, 399 sold).
- Registration Rights: The Company agreed to file a registration statement for the resale of Common Stock issuable upon conversion or warrant exercise within 30 days of closing, with an effectiveness target of 90 days.
Outlook, Risks, and Contingencies
- Stockholder Approval Requirement: Price-based anti-dilution adjustments and the "Additional Investment Right" (allowing holders to invest an additional amount equal to their initial investment at $1,000 per share) require stockholder approval. This approval is a condition to the effectiveness of these features and is anticipated at the next annual meeting in November 2024.
- Dilution Risk: The transaction may result in the issuance of greater than 20% of the Company's Common Stock outstanding at a price less than the conversion price, triggering Nasdaq listing rule requirements for stockholder approval.
- Liquidity and Use of Proceeds: The filing does not explicitly state the intended use of proceeds, though the transaction provides immediate cash liquidity of $399,000.
- Legal Status: Securities are exempt from registration under Section 4(a)(2) and Rule 506(b) of Regulation D; they are restricted and cannot be resold in the U.S. absent registration or an exemption.
Investor Verification Checklist
- Verify the outcome of the stockholder vote at the November 2024 annual meeting regarding anti-dilution adjustments and Additional Investment Rights.
- Confirm the final closing date and receipt of the $399,000 gross proceeds.
- Review the upcoming registration statement (expected within 30 days of closing) for the resale of underlying Common Stock.
- Monitor the Company's periodic reports for updated financial statements to assess the impact of this financing on overall liquidity and debt levels.
- Check for any subsequent filings regarding the exercise of the Placement Agent Warrants or Investor Warrants.